PCSK9 inhibition and type 2 diabetes. (2017)
Attributed to:
Epidemiological contribution to primary and secondary prevention of diabetes and obesity
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s2213-8587(17)30321-2
PubMed Identifier: 28927707
Publication URI: http://europepmc.org/abstract/MED/28927707
Type: Journal Article/Review
Volume: 5
Parent Publication: The lancet. Diabetes & endocrinology
Issue: 12
ISSN: 2213-8587